Punto Health has raised £2m seed funding to develop its speech-based AI platform for early dementia detection and personalised care.
The platform analyses short voice recordings for patterns linked to memory, attention and language change. Those patterns form a digital biomarker, a measurable signal captured by a device.
Punto Health’s multilingual suite includes PuntoTest, a speech-led cognitive assessment for early detection and remote monitoring, PuntoCare, a patient and carer app with daily plans, and PuntoClinic, a clinician dashboard.
The tools have been co-designed and clinically validated with Ace Alzheimer Center Barcelona. In Spain, PuntoTest was used in a rapid screening programme with Ace and Nutricia across ten pharmacies in Barcelona, involving more than 1,500 people aged 50 and above.
PuntoCare is being piloted at North London NHS Foundation Trust, NHS Oxleas Foundation Trust, Hospital del Mar and Hospital General de Granollers. The app supports more than 200 users aged 60 to 90 who have completed over 30,000 activities, and the company says over two-thirds feel better able to manage daily life.
The £2m seed was co-led by Shilling VC and Plus Partners, with Exceptional Ventures, Heartfelt, Fondo Bolsa Social and ABAC Nest joining. It follows a £630,000 pre-seed round and several international programme recognitions.
“Innovation in this area has lagged behind for too long. Punto Health is changing that. Anna and Jack are developing a clinically rigorous AI platform that provides families and healthcare professionals with tools that set a new standard for early detection and personalised care for neurodegenerative diseases. We believe this team is uniquely positioned to expand a solution that will define a category in the healthcare system.” said Tomás Güida, investor at Shilling VC.
“Cognitive impairment and dementia are among the greatest health challenges of our time. Punto Health is building the operating system that will diagnose earlier, guide families and carers, and modernise the entire infrastructure of cognitive care. We are proud to back Anna and Jack, a world-class team bringing the expertise, resilience, and empathy this problem demands.” said Oriol Juncosa, partner at Plus Partners.
“Dementia is never just one person’s disease. It affects entire families, and carers often carry an enormous invisible burden. We are building technology that turns a reactive, crisis-driven system into proactive, personalised support that fits into people’s real lives.” said Anna Muñoz-Farré, co-founder and chief executive at Punto Health.
